153 related articles for article (PubMed ID: 6962825)
1. Reversal of cyclophosphamide induced neutropenia by hypertransfusion and androgen therapy.
DiBenedetto J; Higby DJ; Chester SJ; Albala MM
J Med; 1980; 11(5-6):385-92. PubMed ID: 6962825
[TBL] [Abstract][Full Text] [Related]
2. Acceleration of granulopoietic recovery by androgenic steroids in mice made neutropenic by cytotoxic drugs.
Udupa KB; Reissmann KR
Cancer Res; 1974 Oct; 34(10):2517-20. PubMed ID: 4411809
[No Abstract] [Full Text] [Related]
3. In vitro and in vivo hematopoietic activities of Betafectin PGG-glucan.
Patchen ML; Vaudrain T; Correira H; Martin T; Reese D
Exp Hematol; 1998 Dec; 26(13):1247-54. PubMed ID: 9845381
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous administration of TPO and G-CSF after cytoreductive treatment of rhesus monkeys prevents thrombocytopenia, accelerates platelet and red cell reconstitution, alleviates neutropenia, and promotes the recovery of immature bone marrow cells.
Neelis KJ; Dubbelman YD; Qingliang L; Thomas GR; Eaton DL; Wagemaker G
Exp Hematol; 1997 Sep; 25(10):1084-93. PubMed ID: 9293906
[TBL] [Abstract][Full Text] [Related]
5. A single low dose of human recombinant interleukin 1 accelerates the recovery of neutrophils in mice with cyclophosphamide-induced neutropenia.
Fibbe WE; van der Meer JW; Falkenburg JH; Hamilton MS; Kluin PM; Dinarello CA
Exp Hematol; 1989 Aug; 17(7):805-8. PubMed ID: 2787754
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic stem cell deficit of transplanted bone marrow previously exposed to cytotoxic agents.
Neben S; Hellman S; Montgomery M; Ferrara J; Mauch P
Exp Hematol; 1993 Jan; 21(1):156-62. PubMed ID: 8435103
[TBL] [Abstract][Full Text] [Related]
7. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG
Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878
[TBL] [Abstract][Full Text] [Related]
8. Phase I-II study of high-dose busulfan and cyclophosphamide followed by autologous peripheral blood stem cell transplantation for hematological malignancies: toxicities and hematopoietic recovery.
Ballester OF; Agaliotis DP; Hiemenz JW; Janssen WE; Fields KK; Zorksy PE; Goldstein SC; Perkins JB; Elfenbein GJ
Bone Marrow Transplant; 1996 Jul; 18(1):9-14. PubMed ID: 8831989
[TBL] [Abstract][Full Text] [Related]
9. [Experimental and clinical effect of hypertransfusion and OK-432 on granulocyte recovery].
Nomura T; Kato Y; Atsumi S; Kawaguchi H; Mori F; Shimizu S; Kawamura Y; Kamiya H; Sakurai M; Yatani R
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1850-7. PubMed ID: 6576731
[TBL] [Abstract][Full Text] [Related]
10. Granulocyte-colony stimulating factor impedes recovery from damage caused by cytotoxic agents through increased differentiation at the expense of self-renewal.
van Os R; Robinson S; Sheridan T; Mauch PM
Stem Cells; 2000; 18(2):120-7. PubMed ID: 10742384
[TBL] [Abstract][Full Text] [Related]
11. [Recovery from cyclophosphamide-induced myelosuppression accelerated by bestatin].
Uchida K; Kohi F; Yorimitsu S; Takahashi I; Kitajima K; Kimura I
Gan To Kagaku Ryoho; 1982 Feb; 9(2):220-4. PubMed ID: 7184398
[TBL] [Abstract][Full Text] [Related]
12. Administration of G-CSF can be delayed after transplantation of autologous G-CSF-primed blood stem cells: a randomized study.
Faucher C; Le Corroller AG; Chabannon C; Novakovitch G; Manonni P; Moatti JP; Nouyrigat P; Maraninchi D; Blaise D
Bone Marrow Transplant; 1996 Apr; 17(4):533-6. PubMed ID: 8722350
[TBL] [Abstract][Full Text] [Related]
13. Effect of nandrolone phenpropionate on myelopoiesis.
Kahn SB; Conroy JF; Brodsky I
J Med; 1974; 5(6):303-9. PubMed ID: 4528544
[No Abstract] [Full Text] [Related]
14. Leukopenia and altered hematopoietic activity in mice exposed to the abused inhalant, isobutyl nitrite.
Soderberg LS; Flick JT; Barnett JB
Exp Hematol; 1996 Jun; 24(7):848-53. PubMed ID: 8647236
[TBL] [Abstract][Full Text] [Related]
15. Peripheral blood progenitor cell transplantation: a single centre experience comparing two mobilisation regimens in 67 patients.
Mahendra P; Johnson D; Scott MA; Jestice HK; Hood IM; Ager S; Bass G; Barker P; Boraks PA; Bloxham DM; Baglin TP; Marcus RE
Bone Marrow Transplant; 1996 Apr; 17(4):503-7. PubMed ID: 8722346
[TBL] [Abstract][Full Text] [Related]
16. Effect of cytokine treatment (granulocyte colony-stimulating factor and stem cell factor) on hematopoiesis and the circulating pool of hematopoietic stem cells in mice.
Drize N; Chertkov J; Samoilina N; Zander A
Exp Hematol; 1996 Jun; 24(7):816-22. PubMed ID: 8647232
[TBL] [Abstract][Full Text] [Related]
17. Mobilization of peripheral blood progenitor cells by cyclophosphamide and rhGM-CSF in multiple myeloma.
Martínez E; Sureda A; Dalmases CD; Sánchez JA; Amill B; Tugues D; Sardá P; Miralles A; Brunet S; Domingo-Albós A; García J
Bone Marrow Transplant; 1996 Jul; 18(1):1-7. PubMed ID: 8831988
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic recovery after a single high dose of cyclophosphamide in the mouse.
Scaro JL; Barrio Rendo ME; Alvarez Prado de AR
Acta Physiol Lat Am; 1972; 22(4):258-65. PubMed ID: 4664105
[No Abstract] [Full Text] [Related]
19. Experimental study on safety for granulopoiesis in simultaneous therapy with recombinant human granulocyte colony-stimulating factor and chemotherapy.
Kabaya K; Obuchi M; Watanabe M; Kusaka M; Seki M
Oncol Res; 1995; 7(3-4):165-71. PubMed ID: 8555650
[TBL] [Abstract][Full Text] [Related]
20. In vitro purging of bone marrow with mafosfamide synergizes with in vivo chemotherapy to delay the hematological recovery in a murine model of autologous bone marrow transplantation.
Lopez M; Mary JY; Sainteny F
Exp Hematol; 1993 Feb; 21(2):311-8. PubMed ID: 8425567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]